The surfactant system protects both fetus and newborn

Neonatology

Volumn 103, Issue 4, 2013, Pages 320-326

  Hallman, Mikko ^a,b  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Airway inflammation; Bronchopulmonary dysplasia; Chorioamnionitis; Lung surfactant; Preterm birth; Preterm labor; Respiratory distress syndrome; Term labor

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; GLUCOCORTICOID; INTERLEUKIN 1; LUNG SURFACTANT; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PROSTAGLANDIN E2; SURFACTANT PROTEIN A; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D;

AMNION FLUID; ARTICLE; CHORIOAMNIONITIS; CORTICOSTEROID THERAPY; EVOLUTION; FETUS; FETUS LUNG; FETUS LUNG MATURITY; FETUS MEMBRANE; GENETIC PREDISPOSITION; HUMAN; INTERSTITIAL LUNG DISEASE; LABOR; LABOR INDUCTION; LUNG ALVEOLUS MACROPHAGE; LUNG DYSPLASIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NONHUMAN; PREGNANCY OUTCOME; PREMATURE LABOR; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION;

EID: 84878846413     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000349994     Document Type: Article

References (60)

1. Enhorning G, Robertson B. Lung expansion in the premature rabbit fetus after tracheal deposition of surfactant. Pediatrics 1972; 50: 58-66
2. Halliday HL, Speer CP. Bengt Robertson (1935-2008): a pioneer and leader in surfactant research. Neonatology 2009; 95: VI-VIII
3. Whitsett JA, Wert SE, Weaver TE. Alveolar surfactant homeostasis and the pathogenesis of pulmonary disease. Annu Rev Med 2010; 61: 105-119
4. Jobe AH, Hillman N, Polglase G, Kramer BW, Kallapur S, Pillow J. Injury and inflammation from resuscitation of the preterm infant. Neonatology 2008; 94: 190-196
5. Nkadi PO, Merritt TA, Pillers DA. An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease. Mol Genet Metab 2009; 97: 95-101
6. Ramet M, Korppi M, Hallman M. Pattern recognition receptors and genetic risk for RSV infection: value for clinical decision-making? Pediatr Pulmonol 2011; 46: 101-110
7. Lahti M, Lofgren J, Marttila R, Renko M, Klaavuniemi T, Haataja R, Ramet M, Hallman M. Surfactant protein D gene polymorphism associated with severe respiratory syncytial virus infection. Pediatr Res 2002; 51: 696-699
8. Ramet M, Lofgren J, Alho OP, Hallman M. Surfactant protein-A gene locus associated with recurrent otitis media. J Pediatr 2001; 138: 266-268
9. Paananen R, Postle AD, Clark G, Glumoff V, Hallman M. Eustachian tube surfactant is different from alveolar surfactant: determination of phospholipid composition of porcine eustachian tube lavage fluid. J Lipid Res 2002; 43: 99-106
10. Orgeig S, Hiemstra PS, Veldhuizen EJ, Casals C, Clark HW, Haczku A, Knudsen L, Possmayer F. Recent advances in alveolar biology: evolution and function of alveolar proteins. Respir Physiol Neurobiol 2010; 173(suppl): S43-S54
11. Thomas W, Speer CP. Chorioamnionitis: important risk factor or innocent bystander for neonatal outcome? Neonatology 2011; 99: 177-187
12. Plunkett J, Doniger S, Orabona G, Morgan T, Haataja R, Hallman M, Puttonen H, Menon R, Kuczynski E, Norwitz E, Snegovskikh V, Palotie A, Peltonen L, Fellman V, DeFranco EA, Chaudhari BP, McGregor TL, McElroy JJ, Oetjens MT, Teramo K, Borecki I, Fay J, Muglia L. An evolutionary genomic approach to identify genes involved in human birth timing. PLoS Genet 2011; 7: e1001365
13. Hallman M. Premature birth and diseases in premature infants: common genetic background? J Matern Fetal Neonatal Med 2012; 25(suppl 1): 21-24
14. Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med 2010; 362: 529-535
15. Haataja R, Karjalainen MK, Luukkonen A, Teramo K, Puttonen H, Ojaniemi M, Varilo T, et al. Mapping a new spontaneous preterm birth susceptibility gene, IGF 1R, using linkage, haplotype sharing and association analysis. PLoS Genet 2011; 7: e1011293
16. Karjalainen MK, Huusko JM, Ulvila J, Luukkonen A, Teramo K, Plunkett J, Antila V, et al. A potential novel spontaneous preterm birth gene, AR, identifies by linkage and association analysis of X chromosomal markers. PLoS One 2012; 7: e51378
17. Simmons LE, Rubens CE, Darmstadt GL, Gravett MG. Preventing preterm birth and neonatal mortality: exploring the epidemiology, causes, and interventions. Semin Perinatol 2010; 34: 408-415
18. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371: 75-84
19. Liggins GC. Premature parturition after infusion of corticotrophin or cortisol into foetal lambs. J Endocrinol 1968; 42: 323-329
20. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J Endocrinol 1969; 45: 515-523
21. Khanprakob T, Laopaiboon M, Lumbiganon P, Sangkomkamhang US. Cyclo-oxygenase (COX) inhibitors for preventing preterm labour. Cochrane Database Syst Rev 2012; 10: CD007748
22. Haas DM, Caldwell DM, Kirkpatrick P, Mc-Intosh JJ, Welton NJ. Tocolytic therapy for preterm delivery: systematic review and network meta-Analysis. BMJ 2012; 345: e6226
23. Eronen M, Pesonen E, Kurki T, Teramo K, Ylikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr 1994; 124: 782-788
24. Bry K, Lappalainen U, Hallman M. Intraamniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J Clin Invest 1997; 99: 2992-2999
25. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-215
26. Kramer BW. Chorioamnionitis-new ideas from experimental models. Neonatology 2011; 99: 320-325
27. Speer CP. Chorioamnionitis, postnatal factors and proinflammatory response in the pathogenetic sequence of bronchopulmonary dysplasia. Neonatology 2009; 95: 353-361
28. Jobe AH, Newnham JP, Willet KE, Sly P, Ervin MG, Bachurski C, Possmayer F, Hallman M, Ikegami M. Effects of antenatal endotoxin and glucocorticoids on the lungs of preterm lambs. Am J Obstet Gynecol 2000; 182: 401-408
29. Numata M, Kandasamy P, Voelker DR. Anionic pulmonary surfactant lipid regulation of innate immunity. Expert Rev Respir Med 2012; 6: 243-246
30. Glasser SW, Senft AP, Whitsett JA, Maxfield MD, Ross GF, Richardson TR, Prows DR, Xu Y, Korfhagen TR. Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice. J Immunol 2008; 181: 621-628
31. Ledford JG, Pastva AM, Wright JR. Review: collectins link innate and adaptive immunity in allergic airway disease. Innate Immun 2010; 16: 183-190
32. Condon JC, Jeyasuria P, Faust JM, Mendelson CR. Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition. Proc Natl Acad Sci USA 2004; 101: 4978-4983
33. Salminen A, Vuolteenaho R, Paananen R, Ojaniemi M, Hallman M. Surfactant protein A modulates the lipopolysaccharide-induced inflammatory response related to preterm birth. Cytokine 2011; 56: 442-449
34. Salminen A, Vuolteenaho R, Paananen R, Ojaniemi M, Hallman M. Surfactant protein D modulates levels of IL-10 and TNF-A in intrauterine compartments during lipopolysaccharide-induced preterm birth. Cytokine 2012; 60: 423-430
35. Hallman M, Arjomaa P, Mizumoto M, Akino T. Surfactant proteins in the diagnosis of fetal lung maturity. I. Predictive accuracy of the 35 kD protein, the lecithin/sphingomyelin ratio, and phosphatidylglycerol. Am J Obstet Gynecol 1988; 158: 531-535
36. Miyamura K, Malhotra R, Hoppe HJ, Reid KB, Phizackerley PJ, Macpherson P, Lopez Bernal A. Surfactant proteins A (SP-A) and D (SP-D): levels in human amniotic fluid and localization in the fetal membranes. Biochim Biophys Acta 1994; 1210: 303-307
37. Leth-Larsen R, Garred P, Jensenius H, Meschi J, Hartshorn K, Madsen J, Tornoe I, Madsen HO, Sorensen G, Crouch E, Holmskov U. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 2005; 174: 1532-1538
38. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. By binding SIRP-Alpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003; 115: 13-23
39. Karjalainen MK, Huusko JM, Tuohimaa A, Luukkonen A, Haataja R, Hallman M. A study of collectin genes in spontaneous preterm birth reveals an association with a common surfactant protein D gene polymorphism. Pediatr Res 2012; 71: 93-99
40. Salminen A, Paananen R, Karjalainen MK, Tuohimaa A, Luukkonen A, Ojaniemi M, Jouppila P, Glasser S, Haataja R, Vuolteenaho R, Hallman M. Genetic association of SP-C with duration of preterm premature rupture of fetal membranes and expression in gestational tissues. Ann Med 2009; 41: 629-642
41. Hallman M, Merritt TA, Pohjavuori M, Gluck L. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure. Pediatr Res 1986; 20: 1228-1235
42. Hallman M. Antenatal diagnosis of lung maturity; in Robertson B, Van Golde LM, Batenburg JJ (eds): Pulmonary Surfactant. From Molecular Biology to Clinical Practice. Amsterdam, Elsevier, 1992, pp 425-458
43. Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S, Voutilainen R, Hallman M. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. J Pediatr 2005; 146: 632-637
44. Carnielli VP, Zimmermann LJ, Hamvas A, Cogo PE. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes. J Perinatol 2009; 29(suppl 2): S29-S37
45. Hallman M, Epstein BL, Gluck L. Analysis of labeling and clearance of lung surfactant phospholipids in rabbit. Evidence of bidirectional surfactant flux between lamellar bodies and alveolar lavage. J Clin Invest 1981; 68: 742-751
46. Hallman M, Merritt TA, Akino T, Bry K. Surfactant protein A, phosphatidylcholine, and surfactant inhibitors in epithelial lining fluid. Correlation with surface activity, severity of respiratory distress syndrome, and outcome in small premature infants. Am Rev Respir Dis 1991; 144: 1376-1384
47. Vayrynen O, Glumoff V, Hallman M. Regulation of surfactant proteins by LPS and proinflammatory cytokines in fetal and newborn lung. Am J Physiol Lung Cell Mol Physiol 2002; 282: L803-L810
48. Paananen R, Husa AK, Vuolteenaho R, Herva R, Kaukola T, Hallman M. Blood cytokines during the perinatal period in very preterm infants: relationship of inflammatory response and bronchopulmonary dysplasia. J Pediatr 2009; 154: 39-43
49. Aikio O, Metsola J, Vuolteenaho R, Perhomaa M, Hallman M. Transient defect in nitric oxide generation after rupture of fetal membranes and responsiveness to inhaled nitric oxide in very preterm infants with hypoxic respiratory failure. J Pediatr 2012; 161: 397-403
50. Ikegami M, Jobe AH. Injury responses to different surfactants in ventilated premature lamb lungs. Pediatr Res 2002; 51: 689-695
51. Chabot S, Koumanov K, Lambeau G, Gelb MH, Balloy V, Chignard M, Whitsett JA, Touqui LL. Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2. J Immunol 2003; 171: 995-1000
52. Ikegami M, Carter K, Bishop K, Yadav A, Masterjohn E, Brondyk W, Scheule RK, Whitsett JA. Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb. Am J Respir Crit Care Med 2006; 173: 1342-1347
53. Bersani I, Speer CP, Kunzmann S. Surfactant proteins A and D in pulmonary diseases of preterm infants. Expert Rev Anti Infect Ther 2012; 10: 573-584
54. Hallman M, Haataja R. Genetic basis of respiratory distress syndrome. Front Biosci 2007; 12: 2670-2682
55. Marttila R, Haataja R, Guttentag S, Hallman M. Surfactant protein A and B genetic variants in respiratory distress syndrome in singletons and twins. Am J Respir Crit Care Med 2003; 168: 1216-1222
56. Hamvas A. Current technology in the diagnosis of developmentally related lung disorders. Neonatology 2012; 101: 353-359
57. Wert SE, Whitsett JA, Nogee LM. Genetic disorders of surfactant dysfunction. Pediatr Dev Pathol 2009; 12: 253-274
58. Rova M, Haataja R, Marttila R, Ollikainen V, Tammela O, Hallman M. Data mining and multiparameter analysis of lung surfactant protein genes in bronchopulmonary dysplasia. Hum Mol Genet 2004; 13: 1095-1104
59. Montalbano AP, Hawgood S, Mendelson CR. Mice deficient in surfactant protein A (SP-A) and SP-D or in TLR2 manifest delayed parturition and decreased expression of inflammatory and contractile genes. Endocrinology 2013; 154: 483-498
60. Bry K, Hallman M. Transforming growth factor-beta 2 prevents preterm delivery induced by interleukin-1 alpha and tumor necrosis factor-Alpha in the rabbit. Am J Obstet Gynecol 1993; 168: 1318-1322